테넷 헬스케어 코퍼레이션
| Security | THC / Tenet Healthcare Corporation |
| Insider | Cecil D Haney |
This page shows the track record and history of HANEY CECIL D
insider trades in Tenet Healthcare Corporation. The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company.
It is illegal for insiders to make trades in their companies based on material, non-public information ("MNPI"). This does not mean
it is illegal for them to make any
trades in their own companies. However, they must report all trades to the SEC via a Form 4.
Insider Purchases - Short Term Profit Analysis
In this section, we analyze the profitability of every unplanned, open-market insider purchase made by Cecil D Haney in THC / Tenet Healthcare Corporation. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.
The following table shows the most recent open market purchases that were not part of an automatic trading plan.
| Trade Date | Reported Shares |
Reported Price |
Adjusted Shares |
Adjusted Price |
Cost Basis | Days to Max |
Price at Max |
Max Profit ($) |
Max Return (%) |
|---|---|---|---|---|---|---|---|
| There are no known unplanned open-market trades for this insider |
Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.
Insider Sales - Short Term Loss Analysis
In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made by Cecil D Haney in THC / Tenet Healthcare Corporation. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.
The following table shows the most recent open market purchases that were not part of an automatic trading plan.
| Trade Date | Reported Shares |
Reported Price |
Adjusted Shares |
Adjusted Price |
Cost Basis | Days to Min |
Price at Min |
Max Loss Avoided ($) |
Max Loss Avoided (%) |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-04 | 2,500 | 124.2600 | 2,500 | 124.2600 | 310,650 | 48 | 110.4100 | -34,625 | -11.15 |
Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.
Insider Transaction History
| File Date |
Trade Date |
Form | Insider | Ticker | Security Title | Code | Direct | Exercise Price |
Unit Price |
Units Changed |
Value Changed (1K) |
Remaining Options |
Remaining Shares |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-26 | 2026-05-22 | 4 | HANEY CECIL D | THC | Common Stock | D | 173.7800 | -493 | -86 | 13,853 | ||||
| 2026-05-26 | 2026-05-22 | 4 | HANEY CECIL D | THC | Common Stock | D | 1,333 | 14,346 | ||||||
| 2025-05-27 | 2025-05-23 | 4 | HANEY CECIL D | THC | Common Stock | D | 161.3300 | -573 | -92 | 13,013 | ||||
| 2025-05-27 | 2025-05-23 | 4 | HANEY CECIL D | THC | Common Stock | D | 1,551 | 13,586 | ||||||
| 2025-03-05 | 2025-03-04 | 4 | HANEY CECIL D | THC | Common Stock | D | 124.2600 | -2,500 | -311 | 12,035 | ||||
| 2023-06-23 | 2023-05-26 | 4/A | HANEY CECIL D | THC | Common Stock | D | 3,682 | 14,535 | ||||||
| 2023-05-30 | 2023-05-26 | 4 | HANEY CECIL D | THC | Common Stock | D | 2,846 | 13,699 | ||||||
| 2022-05-11 | 2022-05-09 | 4 | HANEY CECIL D | THC | Common Stock | D | 3,836 | 10,853 | ||||||
| 2021-05-11 | 2021-05-07 | 4 | HANEY CECIL D | THC | Common Stock | D | 3,960 | 7,017 | ||||||
| 2021-01-20 | 2021-01-15 | 4 | HANEY CECIL D | THC | Common Stock | D | 3,057 | 3,057 |
P
공개 시장에서 또는 사적으로 비파생증권 또는 파생증권 매입
S
공개 시장에서 또는 사적으로 비파생증권 또는 파생증권 매각
A
자사로부터 유가증권(옵션 등)을 보조, 지급 또는 기타 취득
C
파생상품 전환
D
자사에게 유가증권을 매각 또는 양도
F
기업으로부터 인도 받은 유가증권의 일부를 사용한 행사 가격 또는 조세 채무의 지급
G
내부자에 의한 또는 내부자에게 증권 증여
K
지분스왑 및 유사 위험 회피거래
M
자사로부터 인도 받은 파생증권(옵션 등)의 행사 또는 전환
V
보고서 양식 4에 자진 신고된 거래
J
기타 (거래 내용을 설명하는 각주와 동반)
